An editorial about the growth in the number of new psychoactive substances (NPS) on the drugs market, also known as ‘legal highs’, ‘bath salts’, or ‘research chemicals’, was published in the section "Editorial and perspective" of Drug Testing and Analysis in the July-August 2014 issue.
James Nutt from Cansford presented at the Scientific Meeting of the Society of Hair Testing (SoHT) on "Hair analysis in the workplace: global harmonisation required", June 2014.
Cansford's sister company in Brazil, ChromaTox, is hosting the 20th Meeting of the Society of Hair Testing (SoHT) in São Paulo in May 2015.
Cansford Laboratories is proud to be the only UK laboratory to be presenting at the Society of Hair Testing for the second year running! Our poster, titled “Hair analysis in the workplace: global harmonisation required”, will be on show in Bordeaux from the 11-13 June 2014.
We pride ourselves on innovation and experience in the field of hair drug testing and are proud to share our knowledge with others.
Data published by the National Programme on Substance Abuse Deaths (NPSAD) has highlighted the increase in drug related deaths due to the use of ‘legal highs’ commonly referred to as Novel Psychoactive Substances (NPS).
The presence of Novel Psychoactive Substances (NPS) in toxicology tests performed for post mortem examinations indicated the prevalence of NPS has increased 800% over three years (2009 – 2012).
Cansford Laboratories presented the increasing incidence of one NPS, Mephedrone (Meow Meow) use at the Society of Hair Testing in Toronto during 2012 (press here for link). Previously, we reported an increase in the number of samples testing positive for Mephedrone (press here for link).
From Cansford laboratory’s data, we are noticing an increasing number of samples testing positive for Amphetamines, with Mephedrone still being positive in around 10% of samples which are analysed for the drug.
The report on NPS also highlights the increasing prevalence of Ketamine derivatives. In samples which have been analysed for the presence of Ketamine, we have experienced a positivity rate of around 43%. The data discussed in this article all relate to our family law cases, as such the relatively high proportion of samples which are positive for Ketamine could be due to known usage of the drug, as a consequence the presence of Ketamine in a hair sample could be expected.
Whilst the analysis of samples for single specific drug groups can be seen as a cost saving measure, the danger is that poly-drug use can be missed. The report comments on the recent rise in the use of Opiates together with other substances in drug-related deaths. The analysis of the Opiates group in isolation could mask poly-drug use in an individual.
The production and supply of legal highs is not an issue which is going to disappear overnight, however, with reports such as the NPSAD report in the public domain, the dangers of NPS together with more “traditional” drugs of abuse can be highlighted.
If you require any further information on the services which Cansford Laboratories are able to offer, including the analysis of Mephedrone and Ketamine in hair or oral fluid, do not hesitate to contact us on 02920 682 031 or send us an email to email@example.com
Thank you for everyone who took part in our “guess the number” competition in Manchester to win a box of luxury chocolates! The staff here at Cansford Laboratories have finally finished checking your entries. It was close, but we have a winner!
And the winning number is…
Topics: Scientific Presentations
James Nutt, Kim Bagley, Lolita Tsanaclis, John Wicks
Cansford Laboratories Ltd. & Cansford Associated Ltd, Cardiff, UK.Tel: 029 2068 2031
Paper presented at the Society of Hair Testing (SoHT), Toronto, Canada, June 2012.
Topics: Scientific Presentations